| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 66758-101-11 | 66758-101 | HUMAN PRESCRIPTION DRUG | HYCAMTIN | topotecan | CAPSULE | ORAL | 20250106 | N/A | NDA | NDA020981 | Sandoz Inc | TOPOTECAN HYDROCHLORIDE | .25 mg/1 | 10 CAPSULE in 1 BOTTLE (66758-101-11) |
| 66758-102-11 | 66758-102 | HUMAN PRESCRIPTION DRUG | HYCAMTIN | topotecan | CAPSULE | ORAL | 20241101 | N/A | NDA | NDA020981 | Sandoz Inc | TOPOTECAN HYDROCHLORIDE | 1 mg/1 | 10 CAPSULE in 1 BOTTLE (66758-102-11) |
| 0078-0672-01 | 0078-0672 | HUMAN PRESCRIPTION DRUG | HYCAMTIN | topotecan | CAPSULE | ORAL | 20170707 | 20251231 | NDA | NDA020981 | Novartis Pharmaceuticals Corporation | TOPOTECAN HYDROCHLORIDE | .25 mg/1 | 10 CAPSULE in 1 BOTTLE (0078-0672-01) |
| 0078-0673-01 | 0078-0673 | HUMAN PRESCRIPTION DRUG | HYCAMTIN | topotecan | CAPSULE | ORAL | 20170224 | 20251231 | NDA | NDA020981 | Novartis Pharmaceuticals Corporation | TOPOTECAN HYDROCHLORIDE | 1 mg/1 | 10 CAPSULE in 1 BOTTLE (0078-0673-01) |